These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8480806)

  • 41. The risks of pharmacological therapy for insomnia (part 1): update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2007; 21(4):188-90. PubMed ID: 17622806
    [No Abstract]   [Full Text] [Related]  

  • 42. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program.
    Singh G
    J Rheumatol; 2001 May; 28(5):1174-9. PubMed ID: 11361209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How can you promote vaccine safety?
    Miller ER; Iskander J; Pickering S; Varricchio F
    Nursing; 2007 Apr; 37(4):58-63; quiz 63-4. PubMed ID: 17413371
    [No Abstract]   [Full Text] [Related]  

  • 45. Reforms on drug safety.
    Nature; 2006 Sep; 443(7110):372. PubMed ID: 17006474
    [No Abstract]   [Full Text] [Related]  

  • 46. Safety of antibiotic drugs in food animals: comparison of findings from preapproval studies and postapproval experience in the United States with safety information in published literature.
    Modric T; Modric S; Murphy MJ; Bright SJ; Shults S
    Vet Clin North Am Food Anim Pract; 2011 Jul; 27(2):389-405, ix. PubMed ID: 21575776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 48. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R; Waltz E
    Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract]   [Full Text] [Related]  

  • 49. Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective.
    Sapirstein W
    Am Heart J; 2001 May; 141(5):861-3. PubMed ID: 11320379
    [No Abstract]   [Full Text] [Related]  

  • 50. Excess mortality related to cefepime.
    Leibovici L; Yahav D; Paul M
    Lancet Infect Dis; 2010 May; 10(5):293-4. PubMed ID: 20417410
    [No Abstract]   [Full Text] [Related]  

  • 51. Policy issues concerning antimicrobials: problems with the regulatory process governing their introduction.
    Simon HJ
    Hosp Formul; 1985 May; 20(5):629-31, 634. PubMed ID: 10271104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care.
    Schiller LR; Johnson DA
    Am J Gastroenterol; 2008 Apr; 103(4):815-9. PubMed ID: 18397418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse event reporting: essential for science and public trust.
    Verma IM
    Mol Ther; 2001 Aug; 4(2):83. PubMed ID: 11482977
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical trials and public trust.
    Kennedy D
    Science; 2004 Dec; 306(5702):1649. PubMed ID: 15576574
    [No Abstract]   [Full Text] [Related]  

  • 55. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(17):4112-21. PubMed ID: 11010653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.
    Kessler DA
    J Am Podiatr Med Assoc; 1994 Jan; 84(1):35-8. PubMed ID: 8295131
    [No Abstract]   [Full Text] [Related]  

  • 57. New law gives FDA more influence to monitor drug safety.
    Wadman M
    Nat Med; 2007 Nov; 13(11):1269. PubMed ID: 17987008
    [No Abstract]   [Full Text] [Related]  

  • 58. Mandatory post marketing studies.
    Somberg J
    Am J Ther; 2007; 14(4):321. PubMed ID: 17667203
    [No Abstract]   [Full Text] [Related]  

  • 59. Ketek--the FDA perspective.
    Soreth J; Cox E; Kweder S; Jenkins J; Galson S
    N Engl J Med; 2007 Apr; 356(16):1675-6. PubMed ID: 17442912
    [No Abstract]   [Full Text] [Related]  

  • 60. A guiding hand for antibiotics.
    Jones D
    Nat Rev Drug Discov; 2011 Mar; 10(3):161-2. PubMed ID: 21358722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.